{"nct_id":"NCT01303380","title":"Canakinumab in Patients With Active Hyper-IgD Syndrome","status":"COMPLETED","status_verified_date":"2015-10","start_date":"2011-03","start_date_type":null,"primary_completion_date":"2014-07","primary_completion_date_type":"ACTUAL","completion_date":"2014-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}